E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease

Chronic low-grade inflammation drives atherosclerosis and despite optimal pharmacological treatment of classical cardiovascular risk factors, one third of the patients with atherosclerotic cardiovascular disease has elevated inflammatory biomarkers. Additional anti-inflammatory strategies to target...

Descripción completa

Detalles Bibliográficos
Autores principales: Poels, Kikkie, Vos, Winnie G., Lutgens, Esther, Seijkens, Tom T. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292335/
https://www.ncbi.nlm.nih.gov/pubmed/32582770
http://dx.doi.org/10.3389/fcvm.2020.00106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292335/
https://www.ncbi.nlm.nih.gov/pubmed/32582770
http://dx.doi.org/10.3389/fcvm.2020.00106

Ejemplares similares